← Open Payments lookup

PRISCILIA NGUH: Open Payments

NPI 1033653787 · SILVER SPRING, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,524 in 49 payments from 12 companies in 2025. Trend: 2023 $300 · 2024 $790 · 2025 $1,524

Food & beverage: $1,524
CompanyPaymentsAmount
ABBVIE INC.6$319
Alkermes, Inc.10$237
Lundbeck LLC8$183
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)8$182
Otsuka America Pharmaceutical, Inc.3$165
Neurocrine BioSciences, Inc.2$162
Axsome Therapeutics, Inc.3$77
Janssen Pharmaceuticals, Inc2$64
E.R. Squibb & Sons, L.L.C.3$56
Teva Pharmaceuticals USA, Inc.2$34

Products named: VRAYLAR, ARISTADA, ABILIFY MAINTENA, CAPLYTA, INGREZZA, REXULTI, Auvelity, INVEGA SUSTENNA.

Industry payments across MD — which companies pay providers there.